Sort
48,018 grants matching “immunotherapy”
Immunomodulatory Biomaterials via Peptide and Protein Self-Assembly
$388,908Joel H Collier · Duke University · R01 · FY2020 · EB
Project 3 Immunotherapeutic Targeting of SLC45A2 for Treatment of Uveal Melanoma
$388,908Cassian Yee · University Of Tx Md Anderson Can Ctr · P50 · FY2021 · CA
Immunomodulatory Biomaterials via Peptide and Protein Self-Assembly
$388,908Joel H Collier · Duke University · R01 · FY2019 · EB
Neural Stem Cell Carriers for Glioblastoma Immunotherapy
$388,890Irina V Balyasnikova · Northwestern University At Chicago · R21 · FY2017 · NS
ANALYSIS OF INTRAHEPATIC MACROPHAGE PROFILES FOR PREDICTING RISK OF FIBROSIS DEVELOPMENT IN PATIENTS WITH DIFFERENT TYPES OF CHRONIC LIVER DISEASE
$388,872Heather L Stevenson · University Of Texas Med Br Galveston · R01 · FY2025 · DK
CANCER AND LEUKEMIA GROUP B
$388,860University Of Chicago · U10 · FY2001 · CA
Targeting the MUC1-C Oncoprotein in Triple-Negative Breast Cancer
$388,836Donald W. Kufe · Dana-Farber Cancer Inst · R01 · FY2022 · CA
Improving specificity of therapeutic antibodies for cancer.
$388,830David A Scheinberg · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
Eradication of Escaped Variant Tumor Cells for Cancer Immunotherapy
$388,825Yong Lu · Methodist Hospital Research Institute · R01 · FY2025 · CA
The Unique Roles of Tumor-Specific Th9 Cells for Solid Tumor Eradication
$388,802Yong Lu · Methodist Hospital Research Institute · R01 · FY2023 · CA
An innovative hemoperfusion nanotrap for sepsis treatment.
$388,800Juntao Luo · Upstate Medical University · R01 · FY2018 · GM
An innovative hemoperfusion nanotrap for sepsis treatment.
$388,800Juntao Luo · Upstate Medical University · R01 · FY2019 · GM
T CELL VACCINE--A CLINICAL TRIAL FOR PROGRESSIVE MS
$388,797University Of Southern California · R01 · FY2002 · NS
Novel mechanism of chemokine nitration in bladder cancer
$388,767Neelam Mukherjee · University Of Texas Hlth Science Center · R01 · FY2025 · CA
The role of AIM2 in T cell-mediated autoimmunity
$388,750Roland Michael Tisch · Univ Of North Carolina Chapel Hill · R01 · FY2019 · AI
Nanoformulated small molecule immunotherapy for SHH medulloblastoma
$388,750Marina Sokolsky-Papkov · Univ Of North Carolina Chapel Hill · R01 · FY2022 · NS
Mechanisms generating suppressor CD4 T cells by thymocyte-mediated development
$388,750Cheong-Hee Chang · University Of Michigan At Ann Arbor · R56 · FY2012 · AI
The role of AIM2 in T cell-mediated autoimmunity
$388,750Roland Michael Tisch · Univ Of North Carolina Chapel Hill · R01 · FY2020 · AI
Activation, Phenotype and Function of CD4 T Cells in Schistosoma-Pulmonary Hypertension
$388,750Brian Barkley Graham · University Of Colorado Denver · R01 · FY2017 · HL
Thymic and peripheral regulation of autoreactive T cells by coreceptor therapy
$388,750Roland Michael Tisch · Univ Of North Carolina Chapel Hill · R01 · FY2019 · AI
The role of AIM2 in T cell-mediated autoimmunity
$388,750Roland Michael Tisch · Univ Of North Carolina Chapel Hill · R01 · FY2021 · AI
Thymic and peripheral regulation of autoreactive T cells by coreceptor therapy
$388,750Roland Michael Tisch · Univ Of North Carolina Chapel Hill · R01 · FY2022 · AI
Thymic and peripheral regulation of autoreactive T cells by coreceptor therapy
$388,750Roland Michael Tisch · Univ Of North Carolina Chapel Hill · R01 · FY2020 · AI
Targeting antigen presentation to enhance GVL responses after Bone Marrow Transpl
$388,750Pavan Reddy · University Of Michigan At Ann Arbor · R01 · FY2016 · HL
Thymic and peripheral regulation of autoreactive T cells by coreceptor therapy
$388,750Roland Michael Tisch · Univ Of North Carolina Chapel Hill · R01 · FY2023 · AI